Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Federal Trade Commission
US Army
Moodys
Fish and Richardson
Cipla

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 8,785,400

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,785,400
Title:Methods and compositions relating to islet cell neogenesis
Abstract: The present invention provides methods and kits for treating diseases and conditions associated with impaired pancreatic function. The present invention further provides methods of stimulating islet cell neogenesis and stimulating islet cell differentiation from progenitor cells.
Inventor(s): Levetan; Claresa S. (Rosemont, PA), Upham; Loraine V. (Albuquerque, NM)
Assignee: CureDM Group Holdings, LLC (Wilmington, DE)
Application Number:11/943,991
Patent Claims:see list of patent claims

Details for Patent 8,785,400

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up CureDM Group Holdings, LLC (Wilmington, DE) 2026-11-22 RX search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 001 2001-05-07 ➤ Sign Up CureDM Group Holdings, LLC (Wilmington, DE) 2026-11-22 RX Orphan search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 002 2001-05-07 ➤ Sign Up CureDM Group Holdings, LLC (Wilmington, DE) 2026-11-22 RX Orphan search
Genzyme LEMTRADA alemtuzumab INJECTABLE;INJECTION 103948 003 2001-05-07 ➤ Sign Up CureDM Group Holdings, LLC (Wilmington, DE) 2026-11-22 RX Orphan search
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27 ➤ Sign Up CureDM Group Holdings, LLC (Wilmington, DE) 2026-11-22 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 8,785,400

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Citi
US Department of Justice
Argus Health
Julphar
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.